Why the study?
Does pindolol reduce blood pressure in patients with stage I or II hypertension?
Does pindolol reduce blood pressure in patients with stage I or II hypertension?
Pindolol significantly lowers blood pressure in hypertensive patients through early reductions in cardiac output and long-term decreases in vascular resistance.
Supports pindolol for BP lowering in hypertension; hypothesis-generating and should not yet change practice.
Five men and five women, mean age 48 years, with hypertension in stages I or II of the WHO classification, were given preoral treatment with pindolol. The pindolol treatment lead a significant decrease in the systolic and diastolic blood pressure, at rest and during work both after 2 months and after 16 months treatment. Three mechanisms seem to be involved in the antihypertensive effect of pindolol: 1) a negative chronotropic effect on the heart, 2) a decrease in peripheral vascular resistance and 3) an increase in venous capacitance affecting the venous return. Comparison of the results after 2 and after 16 months of treatment suggests that a decrease in cardiac output is an early mechanism in the lowering of the blood pressure, while a decrease in vascular resistance seems to be more important after long-term treatment with pindolol.
No takes yet. Share an insight, caveat, or question.
Atterhög et al. (1977) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: